68 related articles for article (PubMed ID: 10544920)
1. Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients.
Diaz-Ricart M; Etebanell E; Cases A; López-Pedret J; Castillo R; Ordinas A; Escolar G
Thromb Haemost; 1999 Oct; 82(4):1312-7. PubMed ID: 10544920
[TBL] [Abstract][Full Text] [Related]
2. Human erythropoietin improves the blood platelet phospholipid composition in chronically hemodialyzed patients.
Krawczyk W; Dmoszyńska A; Marczewski K; Ledwozyw A
Exp Nephrol; 1995; 3(4):265-6. PubMed ID: 8590040
[TBL] [Abstract][Full Text] [Related]
3. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
[TBL] [Abstract][Full Text] [Related]
4. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.
Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G
Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609
[TBL] [Abstract][Full Text] [Related]
5. Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction.
Arderiu G; Díaz-Ricart M; Domenech P; Escolar G; Ordinas A; Pujol-Moix N
Haematologica; 2002 Jun; 87(6):629-36. PubMed ID: 12031920
[TBL] [Abstract][Full Text] [Related]
6. [Effect of human recombinant erythropoietin (rhuEPO) on platelet phospholipids in chronically hemodialysed].
Krawczyk W; Dmoszyńska A; Ledwozyw A; Soroka-Wojtaszko M
Acta Haematol Pol; 1993; 24(4):327-31. PubMed ID: 8303978
[TBL] [Abstract][Full Text] [Related]
7. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy.
Krzesłowska J; Rysz J; Cierniewski CS; Luciak M
Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578
[TBL] [Abstract][Full Text] [Related]
8. Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.
Diaz-Ricart M; Fuste B; Estebanell E; Tonda R; Lozano M; Escolar G; Jamieson G; Ordinas A
Platelets; 2005 Dec; 16(8):453-61. PubMed ID: 16287612
[TBL] [Abstract][Full Text] [Related]
9. Does anemia correction by rHuEPO improve uremic cardiopathy?
Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
Van Geet C; Van Damme-Lombaerts R; Vanrusselt M; de Mol A; Proesmans W; Vermylen J
Thromb Haemost; 1990 Aug; 64(1):7-10. PubMed ID: 2274929
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
Cases A; Escolar G; Reverter JC; Garrido M; Ordinas A; López-Pedret J; Castillo R; Revert L
Med Clin (Barc); 1990 Nov; 95(17):644-7. PubMed ID: 2089202
[TBL] [Abstract][Full Text] [Related]
12. Abnormal cytoskeletal assembly in platelets from uremic patients.
Escolar G; Díaz-Ricart M; Cases A; Castillo R; Ordinas A; White JG
Am J Pathol; 1993 Sep; 143(3):823-31. PubMed ID: 8362980
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin treatment improves platelet function in uremic patients.
Cases A; Escolar G; Reverter JC; Ordinas A; Lopez-Pedret J; Revert L; Castillo R
Kidney Int; 1992 Sep; 42(3):668-72. PubMed ID: 1405344
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin does not modify the prothrombotic effect induced by uremic media on endothelial cells.
Fusté B; Díaz-Ricart M; Cases A; López-Pedret J; Ordinas A; Escolar G
Haematologica; 2002 Sep; 87(9):1006-8. PubMed ID: 12217816
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function.
Tàssies D; Reverter JC; Cases A; Calls J; Escolar G; Ordinas A
Am J Hematol; 1998 Oct; 59(2):105-9. PubMed ID: 9766793
[TBL] [Abstract][Full Text] [Related]
16. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
[TBL] [Abstract][Full Text] [Related]
18. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
[TBL] [Abstract][Full Text] [Related]
19. Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
Małyszko JS; Małyszko J; Pawlak K; Pawlak D; Buczko W; Myśliwiec M
Nephron; 2000 Apr; 84(4):305-11. PubMed ID: 10754406
[TBL] [Abstract][Full Text] [Related]
20. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]